Role of kidney function on Nrf2 mRNA levels in type 2 diabetes

Belinda Spoto,Cristina Politi,Maurizio Postorino,Rosa Maria Parlongo,Alessandra Testa,Giovanni Luigi Tripepi,Francesca Mallamaci,Carmine Zoccali

DOI: https://doi.org/10.1136/bmjdrc-2023-003929

2024-04-05

BMJ Open Diabetes Research & Care

Abstract:Introduction Diabetic kidney disease (DKD) is a major complication in patients with diabetes and the main contributor to the chronic kidney disease (CKD) global burden. Oxidative stress is a crucial factor in DKD pathogenesis but the role of the antioxidant nuclear factor erythroid 2-related factor 2 (Nrf2) and its molecular regulators has been poorly investigated in man. Research design and methods In this case-control study, we analyzed the roles of Nrf2, a transcription factor shielding cells from oxidative stress, its repressor Kelch-like ECH-associated protein 1 (Keap1) and six microRNAs (miRNAs) that potentially suppress Nrf2. We categorized 99 participants into 3 groups: 33 non-dialysis patients with type 2 diabetes with DKD, 33 patients with type 2 diabetes without DKD and 33 control subjects and quantified the gene expression (messenger RNA (mRNA)) levels of Nrf2, Keap1 and 6 miRNAs. Moreover, we studied the correlation between gene expression levels and clinical indicators of kidney health. Results In patients with diabetes with DKD, Nrf2 mRNA levels were significantly lower than in patients without DKD (p=0.01) and controls (p=0.02), whereas no difference in Nrf2 expression levels existed between patients without DKD and controls. Conversely, in patients with and without DKD, Keap1 expression levels were significantly higher than in controls. Of the six miRNAs studied, miRNA 30e-5p showed differential expression, being markedly reduced in patients with DKD (p=0.007). Nrf2 mRNA levels directly correlated with estimated glomerular filtration rate (eGFR) in patients with DKD (r=0.34, p=0.05) and in a formal mediation analysis the eGFR emerged as the first factor in rank for explaining the difference in Nrf2 mRNA levels between patients with and without DKD. Conclusions The observed dysregulation in the Nrf2-Keap1 axis and the unique expression pattern of miRNA30e-5p in DKD underscore the need for more focused research in this domain that can help identify novel intervention strategies for DKD in patients with type 2 diabetes.

endocrinology & metabolism

What problem does this paper attempt to address?

The paper primarily discusses the role of Nuclear factor erythroid 2-related factor 2 (Nrf2) in type 2 diabetic kidney disease (DKD) and its relationship with renal function. The study found that in patients with type 2 diabetes who have DKD, the messenger RNA (mRNA) levels of Nrf2 are significantly lower than those in diabetic patients without DKD and the healthy control group. However, there was no significant difference in Nrf2 expression levels between diabetic patients without DKD and the healthy control group. Additionally, the study observed that the expression levels of Kelch-like ECH-associated protein 1 (Keap1) were higher in both DKD and non-DKD diabetic patients compared to the healthy control group, but Keap1 does not appear to be the key mediator causing oxidative stress damage in DKD. Among the six studied microRNAs (miRNAs), miRNA 30e-5p showed differential expression in DKD patients, with significantly reduced levels. Nrf2 mRNA levels were directly correlated with the estimated glomerular filtration rate (eGFR), especially in DKD patients, and in formal mediation analysis, eGFR was identified as the main factor explaining the difference in Nrf2 mRNA levels between DKD and non-DKD patients.

In summary, the study reveals the dysregulation of the Nrf2-Keap1 axis and the unique expression pattern of miRNA30e-5p in DKD, emphasizing the need for more focused research in this area to help identify new intervention strategies for DKD. These findings could impact the treatment strategies for DKD in patients with type 2 diabetes, suggesting that Nrf2 enhancers such as bardoxolone and CDDO-imidazol may have protective effects. However, the study also points out its limitations, including the observational nature of the study design which limits the inference of causality, and more mechanistic studies are needed in the future to validate these findings.